Photo Credit: Envirotainer
Envirotainer, the global market leader in secure cold chain solutions for intercontinental shipments of pharmaceuticals, is launching the CryoSure® platform with a (minus) 70oC solution.
The four models of the CryoSure® platform are, X1, X2, X5 and X11.
Most temperature-controlled pharmaceutical shipment solutions require below -70°C shipments for pharma products and biospecimen samples, including many new products within Cell & Gene Therapy, Clinical development, other non-finished products as well as mRNA vaccines have to be transported below -70°C.
Envirotainer's newly launched revolutionary CryoSure® platform is based on Linde Seccurus® technology and Envirotainer’s 35 years of experience. With its superior duration of up to 3 weeks, heat resistance and unparalleled ease of use, CryoSure® is the most reliable choice for -70°C cryogenic shipments, and for protecting patient safety.
"This new CryoSure® technology takes pharma transportation to the next level by mitigating most if not all risks currently faced when shipping pharma products below -70°C”, says Mattias Almgren, CryoSure® Platform Executive at Envirotainer.
“This technology fits perfectly into our circular business model and is going to be an important part of our offering going forward. The unique, premium quality, and completely reusable technology matches perfectly into Envirotainer’s global footprint”, says Fredrik Linnér, Chief Business Development Officer at Envirotainer.
